Zobrazeno 1 - 10
of 330
pro vyhledávání: '"Makiko, Shimizu"'
Autor:
Daisuke Negishi, Okimichi Mitsumatsu, Hiromi Mitsumatsu, Miaki Makiguchi, Makiko Shimizu, Hiroshi Yamazaki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-5 (2023)
Abstract Background Tedizolid is a new oxazolidinone antibiotic with high potency for the treatment of infections caused by methicillin-resistant Staphylococcus aureus and other species. Case presentation Two patients with osteoarthritis (women aged
Externí odkaz:
https://doaj.org/article/f44eb9d31c544ba59c0e3f2737e98059
Autor:
Koichiro Adachi1, Makiko Shimizu1, Fumiaki Shono2, Kimito Funatsu2, Hiroshi Yamazaki1 hyamazak@ac.shoyaku.ac.jp
Publikováno v:
Journal of Toxicological Sciences. 2024, Vol. 49 Issue 4, p127-137. 11p.
Autor:
Dong V. Hoang, Shamima Akter, Yosuke Inoue, Keisuke Kuwahara, Ami Fukunaga, Zobida Islam, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Hiroko Okazaki, Toshiaki Miyamoto, Takayuki Ogasawara, Naoko Sasaki, Akihiko Uehara, Makoto Yamamoto, Takeshi Kochi, Masafumi Eguchi, Taiki Shirasaka, Makiko Shimizu, Satsue Nagahama, Ai Hori, Teppei Imai, Akiko Nishihara, Kentaro Tomita, Chihiro Nishiura, Maki Konishi, Isamu Kabe, Kenya Yamamoto, Tetsuya Mizoue, Seitaro Dohi
Publikováno v:
Journal of Epidemiology, Vol 33, Iss 6, Pp 311-320 (2023)
Background: Metabolic syndrome (MetS) has been associated with various chronic diseases that may lead to long-term sickness absence (LTSA), but there is lacking information on the direct association between MetS and LTSA. The present study aimed to i
Externí odkaz:
https://doaj.org/article/a77006b13de84a69905155498502e336
Autor:
Makiko Shimizu, Mitsuhiro Yoshimura, Kazuhiko Baba, Naofumi Ikeda, Yuki Nonaka, Takashi Maruyama, Tatsushi Onaka, Yoichi Ueta
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
IntroductionWithin the realm of chemogenetics, a particular form of agonists targeting designer receptors exclusively activated by designer drugs (DREADDs) has emerged. Deschloroclozapine (DCZ), a recently introduced DREADDs agonist, demonstrates rem
Externí odkaz:
https://doaj.org/article/d9322fcd42b14fb0817aaa3e3fa3fac7
Autor:
Haruki Nishimura, Mitsuhiro Yoshimura, Makiko Shimizu, Kenya Sanada, Satomi Sonoda, Kazuaki Nishimura, Kazuhiko Baba, Naofumi Ikeda, Yasuhito Motojima, Takashi Maruyama, Yuki Nonaka, Ryoko Baba, Tatsushi Onaka, Takafumi Horishita, Hiroyuki Morimoto, Yasuhiro Yoshida, Makoto Kawasaki, Akinori Sakai, Masafumi Muratani, Becky Conway-Campbell, Stafford Lightman, Yoichi Ueta
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-19 (2022)
The analgesic effect of oxytocin appears to be mediated via an oxytocin receptor and endogenous oxytocin contributes to the anti-nociception and anti-inflammatory response.
Externí odkaz:
https://doaj.org/article/5b705d17b31d48fe8095a53fc1367b16
Autor:
Chihiro Nishiura, Yosuke Inoue, Ikuko Kashino, Akiko Nanri, Motoki Endo, Masafumi Eguchi, Takeshi Kochi, Noritada Kato, Makiko Shimizu, Teppei Imai, Akiko Nishihara, Makoto Yamamoto, Hiroko Okazaki, Kentaro Tomita, Toshiaki Miyamoto, Shuichiro Yamamoto, Tohru Nakagawa, Toru Honda, Takayuki Ogasawara, Naoko Sasaki, Ai Hori, Isamu Kabe, Tetsuya Mizoue, Seitaro Dohi
Publikováno v:
Journal of Epidemiology, Vol 32, Iss 9, Pp 431-437 (2022)
Background: While it is essential to understand how long is sufficient for return-to-work when designing paid sick-leave systems, little attempt has been done to collect cause-specific information on when and how many of sickness absentees returned t
Externí odkaz:
https://doaj.org/article/4c82e76385c4413e8a85dc11a28fac4a
Autor:
Daisuke Negishi, Okimichi Mitsumatsu, Takahiro Matsumura, Hiromi Mitsumatsu, Miaki Makiguchi, Makiko Shimizu, Hiroshi Yamazaki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-5 (2022)
Abstract Background Linezolid is a new oxazolidinone antibiotic used for infections caused by methicillin-resistant Staphylococcus and other species. Case presentation Two cases of knee osteoarthritis with acute infection were successfully treated us
Externí odkaz:
https://doaj.org/article/e006239560d74fc98cb1bda85851c857
Autor:
Koichiro Adachi, Satoru Beppu, Mariko Terashima, Toshiaki Fukuda, Jun Tomizawa, Makiko Shimizu, Hiroshi Yamazaki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract Background Caffeine (0.1 g) is used as a central nervous system stimulant and as a nontoxic phenotyping probe for cytochrome P450 1A2. However, an increasing number of suicide attempts by caffeine overdose have been recently reported. Case p
Externí odkaz:
https://doaj.org/article/968e5126ff304c06b60c1ee6cccad19b
Autor:
Koichiro Adachi, Yuki Sugitani, Ryo Unita, Kosuke Yoshida, Satoru Beppu, Mariko Terashima, Masaya Fujii, Makiko Shimizu, Hiroshi Yamazaki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 7, Iss 1, Pp 1-5 (2021)
Abstract Background Loxoprofen is a propionic acid derivative and is the most widely prescribed non-steroidal anti-inflammatory drug in Japan. Loxoprofen is generally considered to be relatively nontoxic. Case presentation A 33-year-old man (body wei
Externí odkaz:
https://doaj.org/article/239879cb02d849f88f723896216f1ca7
Autor:
Koichiro Adachi, Satoru Beppu, Mariko Terashima, Wataru Kobari, Makiko Shimizu, Hiroshi Yamazaki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract Background Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poisoning in patients attempting suicide that led to admissions
Externí odkaz:
https://doaj.org/article/b65731cf4dde47b6997b2d0ee71d3dc9